I'm sure AHR.AX are pawing over the scopping study as we type. The earlier report was delayed and like you I hope this is on time AND hope it is a bottler.
The timing of the Chinese offer is curious (so close to Christmas) and I'm sure they were hoping everyone would jump at high share price of .28c but came a gutser. They wanted a position in the company.
The scope study will be a valuable guide.
